Global mRNA Flu Vaccine Supply, Demand and Key Producers, 2024-2030

Description

The global mRNA Flu Vaccine market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

This report studies the global mRNA Flu Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for mRNA Flu Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of mRNA Flu Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global mRNA Flu Vaccine total production and demand, 2019-2030, (K Units)
Global mRNA Flu Vaccine total production value, 2019-2030, (USD Million)
Global mRNA Flu Vaccine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global mRNA Flu Vaccine consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: mRNA Flu Vaccine domestic production, consumption, key domestic manufacturers and share
Global mRNA Flu Vaccine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global mRNA Flu Vaccine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global mRNA Flu Vaccine production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global mRNA Flu Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, BioNTech, CureVac, Novavax, Sanofi, Inovio Pharmaceuticals, Arcturus Therapeutics Holdings, eTheRNA immunotherapies, Valneva, Vaxart, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World mRNA Flu Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global mRNA Flu Vaccine Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global mRNA Flu Vaccine Market, Segmentation by Type:
    mRNA-1010
    mRNA-1020
    mRNA-1030

Global mRNA Flu Vaccine Market, Segmentation by Application:
    Hospital
    Clinic
    Other

Companies Profiled:
    Moderna
    BioNTech
    CureVac
    Novavax
    Sanofi
    Inovio Pharmaceuticals
    Arcturus Therapeutics Holdings
    eTheRNA immunotherapies
    Valneva
    Vaxart
    Entos Pharmaceuticals
    Abnova Corporation
    Anima Biotech
    Sarepta Therapeutics
    iBio
    Barinthus Biotherapeutics
    Alnylam Pharmaceuticals
    Beam Therapeutics

Key Questions Answered:
1. How big is the global mRNA Flu Vaccine market?
2. What is the demand of the global mRNA Flu Vaccine market?
3. What is the year over year growth of the global mRNA Flu Vaccine market?
4. What is the production and production value of the global mRNA Flu Vaccine market?
5. Who are the key producers in the global mRNA Flu Vaccine market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 mRNA Flu Vaccine Introduction
    1.2 World mRNA Flu Vaccine Supply & Forecast
        1.2.1 World mRNA Flu Vaccine Production Value (2019 & 2023 & 2030)
        1.2.2 World mRNA Flu Vaccine Production (2019-2030)
        1.2.3 World mRNA Flu Vaccine Pricing Trends (2019-2030)
    1.3 World mRNA Flu Vaccine Production by Region (Based on Production Site)
        1.3.1 World mRNA Flu Vaccine Production Value by Region (2019-2030)
        1.3.2 World mRNA Flu Vaccine Production by Region (2019-2030)
        1.3.3 World mRNA Flu Vaccine Average Price by Region (2019-2030)
        1.3.4 North America mRNA Flu Vaccine Production (2019-2030)
        1.3.5 Europe mRNA Flu Vaccine Production (2019-2030)
        1.3.6 China mRNA Flu Vaccine Production (2019-2030)
        1.3.7 Japan mRNA Flu Vaccine Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 mRNA Flu Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 mRNA Flu Vaccine Major Market Trends

2 Demand Summary
    2.1 World mRNA Flu Vaccine Demand (2019-2030)
    2.2 World mRNA Flu Vaccine Consumption by Region
        2.2.1 World mRNA Flu Vaccine Consumption by Region (2019-2024)
        2.2.2 World mRNA Flu Vaccine Consumption Forecast by Region (2025-2030)
    2.3 United States mRNA Flu Vaccine Consumption (2019-2030)
    2.4 China mRNA Flu Vaccine Consumption (2019-2030)
    2.5 Europe mRNA Flu Vaccine Consumption (2019-2030)
    2.6 Japan mRNA Flu Vaccine Consumption (2019-2030)
    2.7 South Korea mRNA Flu Vaccine Consumption (2019-2030)
    2.8 ASEAN mRNA Flu Vaccine Consumption (2019-2030)
    2.9 India mRNA Flu Vaccine Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World mRNA Flu Vaccine Production Value by Manufacturer (2019-2024)
    3.2 World mRNA Flu Vaccine Production by Manufacturer (2019-2024)
    3.3 World mRNA Flu Vaccine Average Price by Manufacturer (2019-2024)
    3.4 mRNA Flu Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global mRNA Flu Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for mRNA Flu Vaccine in 2023
        3.5.3 Global Concentration Ratios (CR8) for mRNA Flu Vaccine in 2023
    3.6 mRNA Flu Vaccine Market: Overall Company Footprint Analysis
        3.6.1 mRNA Flu Vaccine Market: Region Footprint
        3.6.2 mRNA Flu Vaccine Market: Company Product Type Footprint
        3.6.3 mRNA Flu Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: mRNA Flu Vaccine Production Value Comparison
        4.1.1 United States VS China: mRNA Flu Vaccine Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: mRNA Flu Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: mRNA Flu Vaccine Production Comparison
        4.2.1 United States VS China: mRNA Flu Vaccine Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: mRNA Flu Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: mRNA Flu Vaccine Consumption Comparison
        4.3.1 United States VS China: mRNA Flu Vaccine Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: mRNA Flu Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based mRNA Flu Vaccine Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based mRNA Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers mRNA Flu Vaccine Production Value (2019-2024)
        4.4.3 United States Based Manufacturers mRNA Flu Vaccine Production (2019-2024)
    4.5 China Based mRNA Flu Vaccine Manufacturers and Market Share
        4.5.1 China Based mRNA Flu Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers mRNA Flu Vaccine Production Value (2019-2024)
        4.5.3 China Based Manufacturers mRNA Flu Vaccine Production (2019-2024)
    4.6 Rest of World Based mRNA Flu Vaccine Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based mRNA Flu Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers mRNA Flu Vaccine Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers mRNA Flu Vaccine Production (2019-2024)

5 Market Analysis by Type
    5.1 World mRNA Flu Vaccine Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 mRNA-1010
        5.2.2 mRNA-1020
        5.2.3 mRNA-1030
    5.3 Market Segment by Type
        5.3.1 World mRNA Flu Vaccine Production by Type (2019-2030)
        5.3.2 World mRNA Flu Vaccine Production Value by Type (2019-2030)
        5.3.3 World mRNA Flu Vaccine Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World mRNA Flu Vaccine Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Other
    6.3 Market Segment by Application
        6.3.1 World mRNA Flu Vaccine Production by Application (2019-2030)
        6.3.2 World mRNA Flu Vaccine Production Value by Application (2019-2030)
        6.3.3 World mRNA Flu Vaccine Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Moderna
        7.1.1 Moderna Details
        7.1.2 Moderna Major Business
        7.1.3 Moderna mRNA Flu Vaccine Product and Services
        7.1.4 Moderna mRNA Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Moderna Recent Developments/Updates
        7.1.6 Moderna Competitive Strengths & Weaknesses
    7.2 BioNTech
        7.2.1 BioNTech Details
        7.2.2 BioNTech Major Business
        7.2.3 BioNTech mRNA Flu Vaccine Product and Services
        7.2.4 BioNTech mRNA Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 BioNTech Recent Developments/Updates
        7.2.6 BioNTech Competitive Strengths & Weaknesses
    7.3 CureVac
        7.3.1 CureVac Details
        7.3.2 CureVac Major Business
        7.3.3 CureVac mRNA Flu Vaccine Product and Services
        7.3.4 CureVac mRNA Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 CureVac Recent Developments/Updates
        7.3.6 CureVac Competitive Strengths & Weaknesses
    7.4 Novavax
        7.4.1 Novavax Details
        7.4.2 Novavax Major Business
        7.4.3 Novavax mRNA Flu Vaccine Product and Services
        7.4.4 Novavax mRNA Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Novavax Recent Developments/Updates
        7.4.6 Novavax Competitive Strengths & Weaknesses
    7.5 Sanofi
        7.5.1 Sanofi Details
        7.5.2 Sanofi Major Business
        7.5.3 Sanofi mRNA Flu Vaccine Product and Services
        7.5.4 Sanofi mRNA Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Sanofi Recent Developments/Updates
        7.5.6 Sanofi Competitive Strengths & Weaknesses
    7.6 Inovio Pharmaceuticals
        7.6.1 Inovio Pharmaceuticals Details
        7.6.2 Inovio Pharmaceuticals Major Business
        7.6.3 Inovio Pharmaceuticals mRNA Flu Vaccine Product and Services
        7.6.4 Inovio Pharmaceuticals mRNA Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Inovio Pharmaceuticals Recent Developments/Updates
        7.6.6 Inovio Pharmaceuticals Competitive Strengths & Weaknesses
    7.7 Arcturus Therapeutics Holdings
        7.7.1 Arcturus Therapeutics Holdings Details
        7.7.2 Arcturus Therapeutics Holdings Major Business
        7.7.3 Arcturus Therapeutics Holdings mRNA Flu Vaccine Product and Services
        7.7.4 Arcturus Therapeutics Holdings mRNA Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Arcturus Therapeutics Holdings Recent Developments/Updates
        7.7.6 Arcturus Therapeutics Holdings Competitive Strengths & Weaknesses
    7.8 eTheRNA immunotherapies
        7.8.1 eTheRNA immunotherapies Details
        7.8.2 eTheRNA immunotherapies Major Business
        7.8.3 eTheRNA immunotherapies mRNA Flu Vaccine Product and Services
        7.8.4 eTheRNA immunotherapies mRNA Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 eTheRNA immunotherapies Recent Developments/Updates
        7.8.6 eTheRNA immunotherapies Competitive Strengths & Weaknesses
    7.9 Valneva
        7.9.1 Valneva Details
        7.9.2 Valneva Major Business
        7.9.3 Valneva mRNA Flu Vaccine Product and Services
        7.9.4 Valneva mRNA Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Valneva Recent Developments/Updates
        7.9.6 Valneva Competitive Strengths & Weaknesses
    7.10 Vaxart
        7.10.1 Vaxart Details
        7.10.2 Vaxart Major Business
        7.10.3 Vaxart mRNA Flu Vaccine Product and Services
        7.10.4 Vaxart mRNA Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Vaxart Recent Developments/Updates
        7.10.6 Vaxart Competitive Strengths & Weaknesses
    7.11 Entos Pharmaceuticals
        7.11.1 Entos Pharmaceuticals Details
        7.11.2 Entos Pharmaceuticals Major Business
        7.11.3 Entos Pharmaceuticals mRNA Flu Vaccine Product and Services
        7.11.4 Entos Pharmaceuticals mRNA Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Entos Pharmaceuticals Recent Developments/Updates
        7.11.6 Entos Pharmaceuticals Competitive Strengths & Weaknesses
    7.12 Abnova Corporation
        7.12.1 Abnova Corporation Details
        7.12.2 Abnova Corporation Major Business
        7.12.3 Abnova Corporation mRNA Flu Vaccine Product and Services
        7.12.4 Abnova Corporation mRNA Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Abnova Corporation Recent Developments/Updates
        7.12.6 Abnova Corporation Competitive Strengths & Weaknesses
    7.13 Anima Biotech
        7.13.1 Anima Biotech Details
        7.13.2 Anima Biotech Major Business
        7.13.3 Anima Biotech mRNA Flu Vaccine Product and Services
        7.13.4 Anima Biotech mRNA Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 Anima Biotech Recent Developments/Updates
        7.13.6 Anima Biotech Competitive Strengths & Weaknesses
    7.14 Sarepta Therapeutics
        7.14.1 Sarepta Therapeutics Details
        7.14.2 Sarepta Therapeutics Major Business
        7.14.3 Sarepta Therapeutics mRNA Flu Vaccine Product and Services
        7.14.4 Sarepta Therapeutics mRNA Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.14.5 Sarepta Therapeutics Recent Developments/Updates
        7.14.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
    7.15 iBio
        7.15.1 iBio Details
        7.15.2 iBio Major Business
        7.15.3 iBio mRNA Flu Vaccine Product and Services
        7.15.4 iBio mRNA Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.15.5 iBio Recent Developments/Updates
        7.15.6 iBio Competitive Strengths & Weaknesses
    7.16 Barinthus Biotherapeutics
        7.16.1 Barinthus Biotherapeutics Details
        7.16.2 Barinthus Biotherapeutics Major Business
        7.16.3 Barinthus Biotherapeutics mRNA Flu Vaccine Product and Services
        7.16.4 Barinthus Biotherapeutics mRNA Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.16.5 Barinthus Biotherapeutics Recent Developments/Updates
        7.16.6 Barinthus Biotherapeutics Competitive Strengths & Weaknesses
    7.17 Alnylam Pharmaceuticals
        7.17.1 Alnylam Pharmaceuticals Details
        7.17.2 Alnylam Pharmaceuticals Major Business
        7.17.3 Alnylam Pharmaceuticals mRNA Flu Vaccine Product and Services
        7.17.4 Alnylam Pharmaceuticals mRNA Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.17.5 Alnylam Pharmaceuticals Recent Developments/Updates
        7.17.6 Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
    7.18 Beam Therapeutics
        7.18.1 Beam Therapeutics Details
        7.18.2 Beam Therapeutics Major Business
        7.18.3 Beam Therapeutics mRNA Flu Vaccine Product and Services
        7.18.4 Beam Therapeutics mRNA Flu Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.18.5 Beam Therapeutics Recent Developments/Updates
        7.18.6 Beam Therapeutics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 mRNA Flu Vaccine Industry Chain
    8.2 mRNA Flu Vaccine Upstream Analysis
        8.2.1 mRNA Flu Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of mRNA Flu Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 mRNA Flu Vaccine Production Mode
    8.6 mRNA Flu Vaccine Procurement Model
    8.7 mRNA Flu Vaccine Industry Sales Model and Sales Channels
        8.7.1 mRNA Flu Vaccine Sales Model
        8.7.2 mRNA Flu Vaccine Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World mRNA Flu Vaccine Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World mRNA Flu Vaccine Production Value by Region (2019-2024) & (USD Million)
 Table 3. World mRNA Flu Vaccine Production Value by Region (2025-2030) & (USD Million)
 Table 4. World mRNA Flu Vaccine Production Value Market Share by Region (2019-2024)
 Table 5. World mRNA Flu Vaccine Production Value Market Share by Region (2025-2030)
 Table 6. World mRNA Flu Vaccine Production by Region (2019-2024) & (K Units)
 Table 7. World mRNA Flu Vaccine Production by Region (2025-2030) & (K Units)
 Table 8. World mRNA Flu Vaccine Production Market Share by Region (2019-2024)
 Table 9. World mRNA Flu Vaccine Production Market Share by Region (2025-2030)
 Table 10. World mRNA Flu Vaccine Average Price by Region (2019-2024) & (US$/Unit)
 Table 11. World mRNA Flu Vaccine Average Price by Region (2025-2030) & (US$/Unit)
 Table 12. mRNA Flu Vaccine Major Market Trends
 Table 13. World mRNA Flu Vaccine Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
 Table 14. World mRNA Flu Vaccine Consumption by Region (2019-2024) & (K Units)
 Table 15. World mRNA Flu Vaccine Consumption Forecast by Region (2025-2030) & (K Units)
 Table 16. World mRNA Flu Vaccine Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key mRNA Flu Vaccine Producers in 2023
 Table 18. World mRNA Flu Vaccine Production by Manufacturer (2019-2024) & (K Units)
 Table 19. Production Market Share of Key mRNA Flu Vaccine Producers in 2023
 Table 20. World mRNA Flu Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 21. Global mRNA Flu Vaccine Company Evaluation Quadrant
 Table 22. World mRNA Flu Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and mRNA Flu Vaccine Production Site of Key Manufacturer
 Table 24. mRNA Flu Vaccine Market: Company Product Type Footprint
 Table 25. mRNA Flu Vaccine Market: Company Product Application Footprint
 Table 26. mRNA Flu Vaccine Competitive Factors
 Table 27. mRNA Flu Vaccine New Entrant and Capacity Expansion Plans
 Table 28. mRNA Flu Vaccine Mergers & Acquisitions Activity
 Table 29. United States VS China mRNA Flu Vaccine Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China mRNA Flu Vaccine Production Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 31. United States VS China mRNA Flu Vaccine Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 32. United States Based mRNA Flu Vaccine Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers mRNA Flu Vaccine Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers mRNA Flu Vaccine Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers mRNA Flu Vaccine Production (2019-2024) & (K Units)
 Table 36. United States Based Manufacturers mRNA Flu Vaccine Production Market Share (2019-2024)
 Table 37. China Based mRNA Flu Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers mRNA Flu Vaccine Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers mRNA Flu Vaccine Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers mRNA Flu Vaccine Production, (2019-2024) & (K Units)
 Table 41. China Based Manufacturers mRNA Flu Vaccine Production Market Share (2019-2024)
 Table 42. Rest of World Based mRNA Flu Vaccine Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers mRNA Flu Vaccine Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers mRNA Flu Vaccine Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers mRNA Flu Vaccine Production, (2019-2024) & (K Units)
 Table 46. Rest of World Based Manufacturers mRNA Flu Vaccine Production Market Share (2019-2024)
 Table 47. World mRNA Flu Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World mRNA Flu Vaccine Production by Type (2019-2024) & (K Units)
 Table 49. World mRNA Flu Vaccine Production by Type (2025-2030) & (K Units)
 Table 50. World mRNA Flu Vaccine Production Value by Type (2019-2024) & (USD Million)
 Table 51. World mRNA Flu Vaccine Production Value by Type (2025-2030) & (USD Million)
 Table 52. World mRNA Flu Vaccine Average Price by Type (2019-2024) & (US$/Unit)
 Table 53. World mRNA Flu Vaccine Average Price by Type (2025-2030) & (US$/Unit)
 Table 54. World mRNA Flu Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World mRNA Flu Vaccine Production by Application (2019-2024) & (K Units)
 Table 56. World mRNA Flu Vaccine Production by Application (2025-2030) & (K Units)
 Table 57. World mRNA Flu Vaccine Production Value by Application (2019-2024) & (USD Million)
 Table 58. World mRNA Flu Vaccine Production Value by Application (2025-2030) & (USD Million)
 Table 59. World mRNA Flu Vaccine Average Price by Application (2019-2024) & (US$/Unit)
 Table 60. World mRNA Flu Vaccine Average Price by Application (2025-2030) & (US$/Unit)
 Table 61. Moderna Basic Information, Manufacturing Base and Competitors
 Table 62. Moderna Major Business
 Table 63. Moderna mRNA Flu Vaccine Product and Services
 Table 64. Moderna mRNA Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Moderna Recent Developments/Updates
 Table 66. Moderna Competitive Strengths & Weaknesses
 Table 67. BioNTech Basic Information, Manufacturing Base and Competitors
 Table 68. BioNTech Major Business
 Table 69. BioNTech mRNA Flu Vaccine Product and Services
 Table 70. BioNTech mRNA Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. BioNTech Recent Developments/Updates
 Table 72. BioNTech Competitive Strengths & Weaknesses
 Table 73. CureVac Basic Information, Manufacturing Base and Competitors
 Table 74. CureVac Major Business
 Table 75. CureVac mRNA Flu Vaccine Product and Services
 Table 76. CureVac mRNA Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. CureVac Recent Developments/Updates
 Table 78. CureVac Competitive Strengths & Weaknesses
 Table 79. Novavax Basic Information, Manufacturing Base and Competitors
 Table 80. Novavax Major Business
 Table 81. Novavax mRNA Flu Vaccine Product and Services
 Table 82. Novavax mRNA Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Novavax Recent Developments/Updates
 Table 84. Novavax Competitive Strengths & Weaknesses
 Table 85. Sanofi Basic Information, Manufacturing Base and Competitors
 Table 86. Sanofi Major Business
 Table 87. Sanofi mRNA Flu Vaccine Product and Services
 Table 88. Sanofi mRNA Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. Sanofi Recent Developments/Updates
 Table 90. Sanofi Competitive Strengths & Weaknesses
 Table 91. Inovio Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 92. Inovio Pharmaceuticals Major Business
 Table 93. Inovio Pharmaceuticals mRNA Flu Vaccine Product and Services
 Table 94. Inovio Pharmaceuticals mRNA Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. Inovio Pharmaceuticals Recent Developments/Updates
 Table 96. Inovio Pharmaceuticals Competitive Strengths & Weaknesses
 Table 97. Arcturus Therapeutics Holdings Basic Information, Manufacturing Base and Competitors
 Table 98. Arcturus Therapeutics Holdings Major Business
 Table 99. Arcturus Therapeutics Holdings mRNA Flu Vaccine Product and Services
 Table 100. Arcturus Therapeutics Holdings mRNA Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. Arcturus Therapeutics Holdings Recent Developments/Updates
 Table 102. Arcturus Therapeutics Holdings Competitive Strengths & Weaknesses
 Table 103. eTheRNA immunotherapies Basic Information, Manufacturing Base and Competitors
 Table 104. eTheRNA immunotherapies Major Business
 Table 105. eTheRNA immunotherapies mRNA Flu Vaccine Product and Services
 Table 106. eTheRNA immunotherapies mRNA Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. eTheRNA immunotherapies Recent Developments/Updates
 Table 108. eTheRNA immunotherapies Competitive Strengths & Weaknesses
 Table 109. Valneva Basic Information, Manufacturing Base and Competitors
 Table 110. Valneva Major Business
 Table 111. Valneva mRNA Flu Vaccine Product and Services
 Table 112. Valneva mRNA Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. Valneva Recent Developments/Updates
 Table 114. Valneva Competitive Strengths & Weaknesses
 Table 115. Vaxart Basic Information, Manufacturing Base and Competitors
 Table 116. Vaxart Major Business
 Table 117. Vaxart mRNA Flu Vaccine Product and Services
 Table 118. Vaxart mRNA Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 119. Vaxart Recent Developments/Updates
 Table 120. Vaxart Competitive Strengths & Weaknesses
 Table 121. Entos Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 122. Entos Pharmaceuticals Major Business
 Table 123. Entos Pharmaceuticals mRNA Flu Vaccine Product and Services
 Table 124. Entos Pharmaceuticals mRNA Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 125. Entos Pharmaceuticals Recent Developments/Updates
 Table 126. Entos Pharmaceuticals Competitive Strengths & Weaknesses
 Table 127. Abnova Corporation Basic Information, Manufacturing Base and Competitors
 Table 128. Abnova Corporation Major Business
 Table 129. Abnova Corporation mRNA Flu Vaccine Product and Services
 Table 130. Abnova Corporation mRNA Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 131. Abnova Corporation Recent Developments/Updates
 Table 132. Abnova Corporation Competitive Strengths & Weaknesses
 Table 133. Anima Biotech Basic Information, Manufacturing Base and Competitors
 Table 134. Anima Biotech Major Business
 Table 135. Anima Biotech mRNA Flu Vaccine Product and Services
 Table 136. Anima Biotech mRNA Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 137. Anima Biotech Recent Developments/Updates
 Table 138. Anima Biotech Competitive Strengths & Weaknesses
 Table 139. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 140. Sarepta Therapeutics Major Business
 Table 141. Sarepta Therapeutics mRNA Flu Vaccine Product and Services
 Table 142. Sarepta Therapeutics mRNA Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 143. Sarepta Therapeutics Recent Developments/Updates
 Table 144. Sarepta Therapeutics Competitive Strengths & Weaknesses
 Table 145. iBio Basic Information, Manufacturing Base and Competitors
 Table 146. iBio Major Business
 Table 147. iBio mRNA Flu Vaccine Product and Services
 Table 148. iBio mRNA Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 149. iBio Recent Developments/Updates
 Table 150. iBio Competitive Strengths & Weaknesses
 Table 151. Barinthus Biotherapeutics Basic Information, Manufacturing Base and Competitors
 Table 152. Barinthus Biotherapeutics Major Business
 Table 153. Barinthus Biotherapeutics mRNA Flu Vaccine Product and Services
 Table 154. Barinthus Biotherapeutics mRNA Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 155. Barinthus Biotherapeutics Recent Developments/Updates
 Table 156. Barinthus Biotherapeutics Competitive Strengths & Weaknesses
 Table 157. Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 158. Alnylam Pharmaceuticals Major Business
 Table 159. Alnylam Pharmaceuticals mRNA Flu Vaccine Product and Services
 Table 160. Alnylam Pharmaceuticals mRNA Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 161. Alnylam Pharmaceuticals Recent Developments/Updates
 Table 162. Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
 Table 163. Beam Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 164. Beam Therapeutics Major Business
 Table 165. Beam Therapeutics mRNA Flu Vaccine Product and Services
 Table 166. Beam Therapeutics mRNA Flu Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 167. Beam Therapeutics Recent Developments/Updates
 Table 168. Beam Therapeutics Competitive Strengths & Weaknesses
 Table 169. Global Key Players of mRNA Flu Vaccine Upstream (Raw Materials)
 Table 170. Global mRNA Flu Vaccine Typical Customers
 Table 171. mRNA Flu Vaccine Typical Distributors


List of Figures
 Figure 1. mRNA Flu Vaccine Picture
 Figure 2. World mRNA Flu Vaccine Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World mRNA Flu Vaccine Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World mRNA Flu Vaccine Production (2019-2030) & (K Units)
 Figure 5. World mRNA Flu Vaccine Average Price (2019-2030) & (US$/Unit)
 Figure 6. World mRNA Flu Vaccine Production Value Market Share by Region (2019-2030)
 Figure 7. World mRNA Flu Vaccine Production Market Share by Region (2019-2030)
 Figure 8. North America mRNA Flu Vaccine Production (2019-2030) & (K Units)
 Figure 9. Europe mRNA Flu Vaccine Production (2019-2030) & (K Units)
 Figure 10. China mRNA Flu Vaccine Production (2019-2030) & (K Units)
 Figure 11. Japan mRNA Flu Vaccine Production (2019-2030) & (K Units)
 Figure 12. mRNA Flu Vaccine Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World mRNA Flu Vaccine Consumption (2019-2030) & (K Units)
 Figure 15. World mRNA Flu Vaccine Consumption Market Share by Region (2019-2030)
 Figure 16. United States mRNA Flu Vaccine Consumption (2019-2030) & (K Units)
 Figure 17. China mRNA Flu Vaccine Consumption (2019-2030) & (K Units)
 Figure 18. Europe mRNA Flu Vaccine Consumption (2019-2030) & (K Units)
 Figure 19. Japan mRNA Flu Vaccine Consumption (2019-2030) & (K Units)
 Figure 20. South Korea mRNA Flu Vaccine Consumption (2019-2030) & (K Units)
 Figure 21. ASEAN mRNA Flu Vaccine Consumption (2019-2030) & (K Units)
 Figure 22. India mRNA Flu Vaccine Consumption (2019-2030) & (K Units)
 Figure 23. Producer Shipments of mRNA Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for mRNA Flu Vaccine Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for mRNA Flu Vaccine Markets in 2023
 Figure 26. United States VS China: mRNA Flu Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: mRNA Flu Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: mRNA Flu Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers mRNA Flu Vaccine Production Market Share 2023
 Figure 30. China Based Manufacturers mRNA Flu Vaccine Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers mRNA Flu Vaccine Production Market Share 2023
 Figure 32. World mRNA Flu Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World mRNA Flu Vaccine Production Value Market Share by Type in 2023
 Figure 34. mRNA-1010
 Figure 35. mRNA-1020
 Figure 36. mRNA-1030
 Figure 37. World mRNA Flu Vaccine Production Market Share by Type (2019-2030)
 Figure 38. World mRNA Flu Vaccine Production Value Market Share by Type (2019-2030)
 Figure 39. World mRNA Flu Vaccine Average Price by Type (2019-2030) & (US$/Unit)
 Figure 40. World mRNA Flu Vaccine Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 41. World mRNA Flu Vaccine Production Value Market Share by Application in 2023
 Figure 42. Hospital
 Figure 43. Clinic
 Figure 44. Other
 Figure 45. World mRNA Flu Vaccine Production Market Share by Application (2019-2030)
 Figure 46. World mRNA Flu Vaccine Production Value Market Share by Application (2019-2030)
 Figure 47. World mRNA Flu Vaccine Average Price by Application (2019-2030) & (US$/Unit)
 Figure 48. mRNA Flu Vaccine Industry Chain
 Figure 49. mRNA Flu Vaccine Procurement Model
 Figure 50. mRNA Flu Vaccine Sales Model
 Figure 51. mRNA Flu Vaccine Sales Channels, Direct Sales, and Distribution
 Figure 52. Methodology
 Figure 53. Research Process and Data Source

Companies Mentioned

Moderna
BioNTech
CureVac
Novavax
Sanofi
Inovio Pharmaceuticals
Arcturus Therapeutics Holdings
eTheRNA immunotherapies
Valneva
Vaxart
Entos Pharmaceuticals
Abnova Corporation
Anima Biotech
Sarepta Therapeutics
iBio
Barinthus Biotherapeutics
Alnylam Pharmaceuticals
Beam Therapeutics